查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1972632

周边置入中央静脉导管市场：依产品类型、材质、适应症、最终用户、通路划分，全球预测（2026-2032年）

Peripherally Inserted Central Catheter Market by Product Type, Material, Indication, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，周边置入中央静脉导管市场价值将达到 13.5 亿美元，到 2026 年将成长至 14.3 亿美元，到 2032 年将达到 20.9 亿美元，复合年增长率为 6.47%。

主要市场统计数据
基准年 2025 13.5亿美元
预计年份：2026年 14.3亿美元
预测年份 2032 20.9亿美元
复合年增长率 (%) 6.47%

全面介绍现代周边置入中央静脉导管。

周边置入的中央静脉导管如今在急诊、长期治疗以及不断发展的门诊医疗保健系统中扮演着至关重要的角色。临床医生和采购团队越来越重视器械选择，认为这是一个多方面的决策，必须兼顾病患安全、手术效率以及与不断发展的治疗和影像工作流程的兼容性。同时，医院和居家医疗机构也在调整通讯协定，以适应更广泛的适应症，并专注于缩短住院时间和分散式输液。

材料创新、器材设计进步以及医疗服务模式的重组如何改变静脉通路装置的临床实务与采购选择？

由于材料科学的进步、设计创新以及医疗服务体系的重组，周边置入中央静脉导管领域正经历变革。抗菌和抗血栓涂层的最新进展正在改变其临床风险特征，而动力注射设计和多腔结构的出现则满足了复杂的治疗方法和影像检查需求。同时，临床医生正在推进手术导引技术和标准化置入流程的整合，以减少併发症并缩短手术时间。

关税引发的供应链重组和采购应对措施的策略影响：对医疗设备供应商、生产基地和临床可用性的影响

到2025年，一系列关税调整及相关贸易政策变化带来的累积效应，为医疗设备的策略采购和供应商管理引入了新的变数。关键原料和成品医疗设备的进口关税凸显了供应商网路和区域製造地多元化的重要性。因此，采购经理们正在重新评估总到岸成本（TLC），加快双源采购策略的实施，并透过长期合约进行对冲，以降低波动风险，同时确保临床关键器械的供应连续性。

透过深入的細項分析进行精准定位，将产品设计、材料技术、临床环境、治疗适应症和分销动态连结起来。

产品系列丰富多样，涵盖多种选择，包括开放式同轴导管、动力注射导管和带阀同轴导管系统，并提供多腔和单腔配置。这使其能够满足从常规输液到复杂影像引导治疗等广泛的临床需求。材料的选择同样至关重要。聚氨酯和硅胶芯材是主流选择，均提供标准型和涂层型两种规格。涂层型导管具有抗菌和抗血栓特性，可降低感染和阻塞的风险，同时也会影响导管的柔软性和放置性能。

决定静脉通路装置。

区域趋势揭示了美洲、欧洲、中东和非洲以及亚太地区各自独特的需求驱动因素和营运限制因素。每个地区都有其独特的临床实务规范、法规结构和供应链结构。在美洲，大型医疗保健系统的整合以及对门诊静脉治疗日益增长的重视，促使製造商优先研发有助于门诊置管、完善的后续护理通讯协定以及显着降低併发症发生率的医疗器材。这种环境凸显了完善的临床医生培训计画和服务水准协议的重要性日益凸显。

製造商和通路合作伙伴为推动临床应用和在医疗保健领域实现差异化价值所采取的竞争定位和策略措施。

竞争格局包括成熟的医疗设备製造商和专注于临床证据、产品可靠性和综合服务的专业血管通路技术创新公司。主要企业透过投资材料技术、涂层和导管结构来降低手术复杂性和术后併发症，从而实现差异化竞争。策略性併购以及与临床网路和输液服务供应商建立有针对性的伙伴关係关係，正成为加速产品推广和拓展门诊及居家照护服务能力的战术性策略。

製造商、供应商和经销商为改善临床结果、增强供应韧性和实现商业性差异化而应采取的切实策略重点。

产业领导者应优先考虑将产品创新、供应链韧性和临床医生能力提升相结合的协作模式。首先，加速涂层和抗血栓材料的研发和临床检验，可以解决长期存在的安全隐患，并在门诊静脉输液治疗和长期照护领域创造明确的价值提案。其次，实现製造地多元化并采用灵活的生产模式，可以提高对区域需求波动的应对力，同时降低关税带来的成本压力。

为了确保实务见解，我们采用严格的混合调查方法，结合临床医师的初步访谈、二次技术分析和专家检验。

本分析基于调查方法，该方法系统地整合了对临床医生、采购经理和行业专家的访谈，以及监管申报文件、临床文献和医疗设备技术文件等二手资料。手术医生和液体管理专家的定性见解与产品规格和材料性能数据进行三角验证，从而能够对临床和营运影响进行可靠的解读。在条件允许的情况下，也查阅了上市后监测报告和不利事件资料库，以了解安全性和併发症趋势的背景资讯。

总之，我们彙编了一套综合的临床、营运和策略要求，以指导血管通路设备的选择、采购和创新。

总之，周边置入中央静脉导管的发展轨迹受到多种因素的共同影响，包括材料和设计的创新、向门诊和居家医疗的转变，以及贸易政策导致的供应链日益复杂化。投资于经临床检验的涂层技术、灵活的设备配置以及完善的医护人员培训的相关人员，最能满足病患安全和营运效率的双重需求。策略性的供应链重组和区域商业化计画对于在保持临床绩效标准的同时应对成本压力至关重要。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章周边置入中央静脉导管市场：依产品类型划分

  • 开口同轴导管
    • 多流明
    • 单流明
  • 可注入式电源
    • 多流明
    • 单流明
  • 带阀门的同轴导管
    • 多流明
    • 单流明

第九章周边置入中央静脉导管市场：依材质

  • 聚氨酯
    • 抗菌涂层
    • 标准聚氨酯
  • 硅酮
    • 抗血栓涂层
    • 标准硅胶

第十章周边置入中央静脉导管市场：依适应症划分

  • 抗生素治疗
    • 长期治疗
    • 短期治疗
  • 化疗
    • 血液治疗
    • 固态肿瘤的治疗
  • 点滴疗法
    • 重症监护输液
    • 水疗法
    • 疼痛管理输液
  • 肠外营养
    • 部分肠外营养
    • 全肠外营养

第十一章周边置入中央静脉导管市场：依最终用户划分

  • 门诊手术中心
    • 医院附设中心
    • 独立中心
  • 透析中心
    • 医院安装型
    • 独立的
  • 居家医疗设施
    • 家庭输液服务
    • 护理机构
  • 医院
    • 当地医院
    • 专科医院

第十二章周边置入中央静脉导管市场：依通路划分

  • 医院药房
    • 外部药房
    • 医院药房
  • 线上销售
    • 厂商直销
    • 经销平台
  • 零售药房
    • 连锁药局
    • 独立药房

第十三章周边置入中央静脉导管市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章周边置入中央静脉导管市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章周边置入中央静脉导管市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国：周边置入中央静脉导管市场

第十七章 中国：周边置入中央静脉导管市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AngioDynamics, Inc.
  • B. Braun Melsungen AG
  • Becton Dickinson and Company
  • Cook Medical LLC
  • ICU Medical, Inc.
  • Medical Components, Inc.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • PFM Medical, Inc.
  • Poly Medicure Ltd.
  • Smiths Group plc
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-9A6A6F2976B4

The Peripherally Inserted Central Catheter Market was valued at USD 1.35 billion in 2025 and is projected to grow to USD 1.43 billion in 2026, with a CAGR of 6.47%, reaching USD 2.09 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.35 billion
Estimated Year [2026] USD 1.43 billion
Forecast Year [2032] USD 2.09 billion
CAGR (%) 6.47%

A comprehensive introduction to the clinical significance, delivery settings, and decision drivers that define contemporary peripherally inserted central catheter use

Peripherally inserted central catheters now occupy a critical intersection between acute care, long-term therapy, and the expanding outpatient ecosystem. Clinicians and procurement teams increasingly view device selection as a multidimensional decision that must balance patient safety, procedural efficiency, and compatibility with evolving therapeutic and imaging workflows. In parallel, hospitals and home care providers are adapting protocols to accommodate broader indications and an increasing emphasis on reduced hospital stays and decentralized infusion delivery.

This introduction establishes the clinical scope, supply chain influences, and the regulatory and reimbursement forces that shape adoption. It sets the stage for a deeper assessment of technological inflections, material science advances, and shifting care delivery models that together determine the trajectory of device development and clinical uptake.

How material innovations, device design advances, and care delivery reconfiguration are reshaping clinical practice and procurement choices for vascular access devices

The landscape for peripherally inserted central catheters is experiencing transformative shifts driven by advances in material science, design innovation, and care delivery reconfiguration. Recent developments in antimicrobial and antithrombogenic coatings are changing clinical risk profiles, while the emergence of power-injectable designs and multi-lumen configurations addresses complex therapeutic regimens and imaging requirements. At the same time, clinicians are integrating procedural guidance technologies and standardized insertion bundles that reduce complications and shorten procedure times.

Concurrently, health systems are altering care pathways to move more infusion and long-term therapies into ambulatory and home-based settings, which accelerates demand for devices optimized for outpatient placement, durability, and maintenance by multidisciplinary teams. Together, these shifts underscore a transition from single-dimension device selection toward a holistic evaluation that includes procedural ecosystem compatibility, lifecycle resource needs, and patient-centered outcomes.

Strategic implications of tariff-driven supply chain realignments and procurement responses that influence device sourcing, production footprints, and clinical availability

The cumulative effect of tariff adjustments and related trade policy changes announced through 2025 has introduced new variables into strategic sourcing and supplier management for medical devices. Import duties on critical raw materials and finished medical devices have amplified the importance of diversified supplier networks and regional manufacturing footprints. As a result, procurement leaders are revisiting total landed cost calculations, accelerating dual-sourcing strategies, and engaging in longer-term contractual hedges to mitigate volatility while preserving supply continuity for clinically critical devices.

In response to these pressures, several manufacturers and distributors have reprioritized regional production and local inventory buffers to reduce exposure to cross-border tariff fluctuations. This reorientation has meaningful implications for lead times, product configuration decisions tied to material substitutions, and the negotiation dynamics between providers and suppliers. Clinicians and supply chain teams must now weigh the trade-offs between near-term cost pressures and the longer-term clinical performance characteristics that influence patient outcomes.

Insightful segmentation analysis bridging product design, material technology, clinical setting, therapeutic indication, and distribution dynamics for precision positioning

The product landscape is multifaceted, encompassing open ended coaxial designs, power-injectable options, and valved coaxial systems with configurations available in multi-lumen and single-lumen variants to address a range of clinical requirements from routine infusions to complex imaging-compatible therapies. Material selection plays a parallel role: polyurethane and silicone core substrates dominate, each available in standard and coated formulations that provide antimicrobial or antithrombogenic properties intended to reduce infection and occlusion risks while influencing catheter flexibility and dwell characteristics.

End-user diversity amplifies segmentation complexity because device specifications must align with the operational realities of ambulatory surgery centers, dialysis centers, home care settings, and hospitals, which themselves include affiliated versus independent centers, hospital-based versus standalone dialysis units, and community versus specialty hospitals. Clinical indications further influence selection criteria, with antibiotic therapy, chemotherapy, infusion therapy, and parenteral nutrition encompassing subtypes such as long-term versus short-term antibiotic regimens, hematological versus solid tumor chemotherapy protocols, and differentiated infusion therapy needs like critical care infusion versus hydration or pain management. Distribution channels-hospital pharmacies, online direct manufacturer or distributor platforms, and retail pharmacies spanning chain and independent outlets-add another dimension of commercialization strategy, impacting product availability, clinician education, and post-market support models.

Regional dynamics and cross-border considerations that determine adoption pathways, regulatory approaches, and distribution strategies for vascular access devices

Regional dynamics reveal differentiated demand drivers and operational constraints across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each presenting distinct clinical practice norms, regulatory frameworks, and supply chain architectures. In the Americas, consolidation among large health systems and an emphasis on outpatient infusion growth push manufacturers to prioritize devices that facilitate ambulatory placement, robust post-insertion care protocols, and demonstrable reductions in complication rates. This environment elevates the importance of strong clinician training programs and service-level agreements.

In Europe, the Middle East & Africa, and the Asia-Pacific regions, regulatory timelines, reimbursement policies, and local manufacturing capacity collectively shape product introduction strategies and commercialization pathways. Organizations operating across these regions must reconcile global design standards with localized needs, balancing centralized R&D with regional adaptation. Consequently, cross-border coordination, regional clinical evidence generation, and strategic partnerships with local distributors or clinical networks are critical to scalable adoption and sustained performance across heterogeneous healthcare ecosystems.

Competitive positioning and strategic levers employed by manufacturers and channel partners to drive clinical adoption and differentiated value across care settings

The competitive environment is populated by established medical device manufacturers and specialized vascular access innovators that emphasize clinical evidence, product reliability, and integrated services. Leading firms are differentiating through investments in material technologies, coatings, and catheter architectures that reduce procedural complexity and post-insertion complications. Strategic M&A and targeted partnerships with clinical networks or infusion service providers have emerged as tactical levers to accelerate product adoption and extend service capabilities into ambulatory and home-based care channels.

Innovators that pair device performance with digital or procedural support-such as clinician training platforms, insertion aids, and post-market surveillance tools-gain preferential access to integrated health systems focused on outcomes-based procurement. Meanwhile, distribution and logistics partners that provide configurable supply arrangements, rapid replenishment, and clinical education services strengthen manufacturer propositions and influence purchasing decisions at the hospital and outpatient levels.

Actionable strategic priorities for manufacturers, providers, and distributors to enhance clinical outcomes, supply resilience, and commercial differentiation

Industry leaders should prioritize a coordinated approach that aligns product innovation with supply chain resilience and clinician enablement. First, accelerating the development and clinical validation of coated and antithrombogenic materials will address persistent safety concerns and create clearer value propositions for outpatient infusion and long-term therapies. Second, diversifying manufacturing footprints and adopting flexible production models can reduce exposure to tariff-driven cost pressures while improving responsiveness to regional demand shifts.

Moreover, investing in clinician training programs, standardized insertion bundles, and post-insertion support services will drive better outcomes and reduce total care burdens. Manufacturers and providers should form collaborative pilot programs to evaluate device performance across relevant end-user settings and indications, ensuring that procurement decisions reflect real-world use cases. Finally, integrating data capture and outcome analytics into product offerings will support value-based negotiations and demonstrate the clinical and operational benefits necessary to secure preferred status with major health systems and payers.

A rigorous mixed-methods research methodology integrating primary clinician interviews, secondary technical analysis, and expert validation to ensure actionable insights

The analysis is grounded in a systematic methodology that synthesized primary interviews with clinicians, procurement leaders, and industry experts alongside secondary sources including regulatory filings, clinical literature, and device technical documentation. Qualitative insights from proceduralists and infusion specialists were triangulated with product specifications and materials performance data to ensure robust interpretation of clinical and operational implications. Where available, post-market surveillance reports and adverse event databases were reviewed to contextualize safety and complication trends.

To enhance rigor, the research applied an iterative validation process with subject-matter experts to reconcile divergent perspectives and refine key assumptions. Limitations include variable transparency in supplier cost components and incomplete disclosure of proprietary clinical registry outcomes, which were mitigated through cross-referenced interviews and independent technical assessments. The result is a disciplined synthesis designed to inform strategic decisions without relying on opaque or single-source inputs.

Concluding synthesis of clinical, operational, and strategic imperatives that will guide device selection, procurement, and innovation for vascular access

In conclusion, the trajectory of peripherally inserted central catheters is being shaped by convergent forces-material and design innovation, evolving care delivery into ambulatory and home settings, and heightened supply chain complexity driven by trade policies. Stakeholders who invest in clinically validated coatings, flexible device configurations, and robust clinician education will be best positioned to meet the dual imperatives of patient safety and operational efficiency. Strategic supply chain realignment and regional commercialization planning will be essential to navigate cost pressures while maintaining clinical performance standards.

As organizations translate these insights into procurement and R&D roadmaps, the emphasis must remain on evidence-based device selection and the integration of lifecycle support services that reduce complication rates and total procedural burden. By aligning product development, distribution strategy, and clinician enablement, device manufacturers and health systems can collaboratively advance vascular access care while managing evolving regulatory and economic constraints.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peripherally Inserted Central Catheter Market, by Product Type

  • 8.1. Open Ended Coaxial
    • 8.1.1. Multi Lumen
    • 8.1.2. Single Lumen
  • 8.2. Power Injectable
    • 8.2.1. Multi Lumen
    • 8.2.2. Single Lumen
  • 8.3. Valved Coaxial
    • 8.3.1. Multi Lumen
    • 8.3.2. Single Lumen

9. Peripherally Inserted Central Catheter Market, by Material

  • 9.1. Polyurethane
    • 9.1.1. Antimicrobial Coated
    • 9.1.2. Standard Polyurethane
  • 9.2. Silicone
    • 9.2.1. Antithrombogenic Coated
    • 9.2.2. Standard Silicone

10. Peripherally Inserted Central Catheter Market, by Indication

  • 10.1. Antibiotic Therapy
    • 10.1.1. Long Term Therapy
    • 10.1.2. Short Term Therapy
  • 10.2. Chemotherapy
    • 10.2.1. Hematological Therapy
    • 10.2.2. Solid Tumor Therapy
  • 10.3. Infusion Therapy
    • 10.3.1. Critical Care Infusion
    • 10.3.2. Hydration Therapy
    • 10.3.3. Pain Management Infusion
  • 10.4. Parenteral Nutrition
    • 10.4.1. Partial Parenteral Nutrition
    • 10.4.2. Total Parenteral Nutrition

11. Peripherally Inserted Central Catheter Market, by End User

  • 11.1. Ambulatory Surgery Centers
    • 11.1.1. Hospital Affiliated Centers
    • 11.1.2. Independent Centers
  • 11.2. Dialysis Centers
    • 11.2.1. Hospital Based
    • 11.2.2. Standalone
  • 11.3. Home Care Settings
    • 11.3.1. Home Infusion Services
    • 11.3.2. Skilled Nursing Facilities
  • 11.4. Hospitals
    • 11.4.1. Community Hospitals
    • 11.4.2. Specialty Hospitals

12. Peripherally Inserted Central Catheter Market, by Distribution Channel

  • 12.1. Hospital Pharmacies
    • 12.1.1. External Pharmacies
    • 12.1.2. In House Pharmacies
  • 12.2. Online Sales
    • 12.2.1. Direct Manufacturer
    • 12.2.2. Distributor Platforms
  • 12.3. Retail Pharmacies
    • 12.3.1. Chain Pharmacies
    • 12.3.2. Independent Pharmacies

13. Peripherally Inserted Central Catheter Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Peripherally Inserted Central Catheter Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Peripherally Inserted Central Catheter Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Peripherally Inserted Central Catheter Market

17. China Peripherally Inserted Central Catheter Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AngioDynamics, Inc.
  • 18.6. B. Braun Melsungen AG
  • 18.7. Becton Dickinson and Company
  • 18.8. Cook Medical LLC
  • 18.9. ICU Medical, Inc.
  • 18.10. Medical Components, Inc.
  • 18.11. Medtronic plc
  • 18.12. Merit Medical Systems, Inc.
  • 18.13. PFM Medical, Inc.
  • 18.14. Poly Medicure Ltd.
  • 18.15. Smiths Group plc
  • 18.16. Teleflex Incorporated
  • 18.17. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY OPEN ENDED COAXIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY OPEN ENDED COAXIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY OPEN ENDED COAXIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY OPEN ENDED COAXIAL, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MULTI LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MULTI LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MULTI LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SINGLE LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SINGLE LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POWER INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POWER INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POWER INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POWER INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MULTI LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MULTI LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MULTI LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SINGLE LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SINGLE LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY VALVED COAXIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY VALVED COAXIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY VALVED COAXIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY VALVED COAXIAL, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MULTI LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MULTI LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MULTI LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SINGLE LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SINGLE LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTIMICROBIAL COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTIMICROBIAL COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTIMICROBIAL COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY STANDARD POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY STANDARD POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY STANDARD POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SILICONE, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTITHROMBOGENIC COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTITHROMBOGENIC COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTITHROMBOGENIC COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY STANDARD SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY STANDARD SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY STANDARD SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTIBIOTIC THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTIBIOTIC THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTIBIOTIC THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY LONG TERM THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY LONG TERM THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY LONG TERM THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SHORT TERM THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SHORT TERM THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SHORT TERM THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HEMATOLOGICAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HEMATOLOGICAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HEMATOLOGICAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SOLID TUMOR THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SOLID TUMOR THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SOLID TUMOR THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INFUSION THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INFUSION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INFUSION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CRITICAL CARE INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CRITICAL CARE INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CRITICAL CARE INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HYDRATION THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HYDRATION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HYDRATION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PAIN MANAGEMENT INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PAIN MANAGEMENT INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PAIN MANAGEMENT INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PARENTERAL NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PARENTERAL NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PARTIAL PARENTERAL NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PARTIAL PARENTERAL NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PARTIAL PARENTERAL NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INDEPENDENT CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INDEPENDENT CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INDEPENDENT CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DIALYSIS CENTERS, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY STANDALONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY STANDALONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY STANDALONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOME INFUSION SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOME INFUSION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOME INFUSION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SKILLED NURSING FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SKILLED NURSING FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SKILLED NURSING FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SPECIALTY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SPECIALTY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SPECIALTY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY EXTERNAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY EXTERNAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY EXTERNAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY IN HOUSE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY IN HOUSE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY IN HOUSE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DIRECT MANUFACTURER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DIRECT MANUFACTURER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DIRECT MANUFACTURER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DISTRIBUTOR PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DISTRIBUTOR PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DISTRIBUTOR PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 171. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 172. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY OPEN ENDED COAXIAL, 2018-2032 (USD MILLION)
  • TABLE 174. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POWER INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 175. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY VALVED COAXIAL, 2018-2032 (USD MILLION)
  • TABLE 176. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 177. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 178. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SILICONE, 2018-2032 (USD MILLION)
  • TABLE 179. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 180. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2032 (USD MILLION)
  • TABLE 181. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 182. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 183. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 184. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 186. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DIALYSIS CENTERS, 2018-2032 (USD MILLION)
  • TABLE 187. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 188. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 189. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 191. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 192. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY OPEN ENDED COAXIAL, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POWER INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY VALVED COAXIAL, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SILICONE, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DIALYSIS CENTERS, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 212. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 214. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY OPEN ENDED COAXIAL, 2018-2032 (USD MILLION)
  • TABLE 218. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POWER INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY VALVED COAXIAL, 2018-2032 (USD MILLION)
  • TABLE 220. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SILICONE, 2018-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 224. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 226. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 228. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 230. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DIALYSIS CENTERS, 2018-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 232. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 234. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 236. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY OPEN ENDED COAXIAL, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POWER INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY VALVED COAXIAL, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SILICONE, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DIALYSIS CENTERS, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY OPEN ENDED COAXIAL, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POWER INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPE PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY VALVED COAXIAL, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPE PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPE PERIPHERALLY INSER